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Abstract
The CD200R1:CD200 axis is traditionally considered to limit tissue inflammation by down-regulating pro-inflammatory
signaling in myeloid cells bearing the receptor. We generated CD200R1
2/2 mice and employed them to explore both the
role of CD200R1 in regulating macrophage signaling via TLR2 as well as the host response to an in vivo, TLR2-dependent
model, herpes simplex virus 1 (HSV-1) infection. CD200R1
2/2 peritoneal macrophages demonstrated a 70–75% decrease in
the generation of IL-6 and CCL5 (Rantes) in response to the TLR2 agonist Pam2CSK4 and to HSV-1. CD200R1
2/2
macrophages could neither up-regulate the expression of TLR2, nor assemble a functional inflammasome in response to
HSV-1. CD200R1
2/2 mice were protected from HSV-1 infection and exhibited dysfunctional TLR2 signaling. Finally, both
CD200R1
2/2 mice and CD200R1
2/2 fibroblasts and macrophages showed a markedly reduced ability to support HSV-1
replication. In summary, our data demonstrate an unanticipated and novel requirement for CD200R1 in ‘‘licensing’’ pro-
inflammatory functions of TLR2 and in limiting viral replication that are supported by ex vivo and in vivo evidence.
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Introduction
The host response to viral pathogens is initiated by the
interaction of viruses, viral genomes, viral proteins, and viral
replication intermediates with host pathogen recognition receptors
(PRRs) to trigger the release of cytokines, chemokines, and
interferons (IFN) [1,2,3,4,5,6]. Ultimately, cells and organisms
must integrate input from different signaling pathways in the
correct temporal and spatial manner to achieve an appropriate
functional state and biological response. In the case of herpes
simplex virus 1 (HSV-1) the interaction of the virus with Toll-like
receptor (TLR) 2 is critical.
The interaction of TLR2 with HSV-1 triggers NF-kB de-
pendent cytokine production [6,7,8,9] leading to the recruitment
and maturation of effector cells for pathogen clearance. Excessive
signaling through TLR2 can cause a ‘‘cytokine storm’’, leading to
excessive inflammation and tissue damage resulting in a potentially
lethal outcome [7,9,10,11]. In response to HSV-1 infection,
TLR2
2/2 mice show both dramatically enhanced survival and
attenuated intracranial generation of CCL5 (Rantes), CCL2
(MCP-1) and IL-6; levels of these cytokines are directly correlated
with the severity of HSV-1 infection and the development of
immunopathology [9,12,13,14,15]. Therefore, survival from
HSV-1 encephalitis is determined not only by lytic viral infection
but also by the balance between pro-inflammatory and down-
regulatory anti-inflammatory mechanisms (as well as anti-viral
signaling pathways) that limit the pro-inflammatory TLR2 re-
sponse to infection. However, down-regulatory pathways that
interface with TLR2 signaling are poorly described. The HSV-1
model of encephalitis is an ideal model to probe the role of how
down-regulatory pathways impact TLR2 biology.
Mouse CD200R1 is a 326 amino acid glycoprotein expressed
on the surface of myeloid and glial cells [16]. CD200R1 interacts
with CD200, which is expressed on the surface of neurons,
epithelial cells, endothelial cells, and lymphocytes [17,18].
CD200R1 has a 67 amino acid intracellular domain with a unique
inhibitory tyrosine motif. Stimulation of CD200R1 by CD200
leads to the phosphorylation of these tyrosines, which recruit the
adapter proteins Docking Proteins (Doks) 2 and 1 and SH2
domain-containing phosphatase-1 (SHP-1) to initiate inhibitory
signaling and suppress cytokine and chemokine generation
[19,20,21]. In contrast to CD200R1, the small cytoplasmic
domain of CD200 lacks a signaling motif [16,17]. The interaction
of CD200 with CD200R1 down-regulates innate and adaptive
immune responses in models of experimental autoimmune
encephalitis (EAE), arthritis, transplantation, and acute pulmonary
inflammation [16,17,18,22]. However, the specific pro-inflamma-
tory signal transduction pathways in macrophages, dendritic cells,
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are poorly described. Specifically, how CD200R1 impacts TLR2
signaling, particularly in macrophages, is not known.
Studies of the role of CD200R1:CD200 interactions in de-
termining the host response to pathogens are complex. To date,
they have employed CD200
2/2 mice, limiting their scope to
probing the entire CD200:CD200R1 axis and not capable of
detecting other roles for CD200R1 in myeloid cells, i.e., intrinsic
functions of CD200R1 independent of CD200 ligand interaction.
In the case of influenza and meningococcus, CD200
2/2 mice are
prone to the effects of inflammation/sepsis [18,23]. This is also the
case for Toxoplasma encephalitis [24]. In regards to Leishmania,
redox defense mechanisms used by the host are suppressed by the
CD200R1:CD200 axis in L. amazonensis, which induces CD200
expression in host cells, so that CD200
2/2 mice are protected
from the pathogen. However L. major grows more slowly in
macrophages and does not induce CD200 expression in host tissue
[25]. More recently studies of mouse hepatitis corona virus [26]
have shown that the release of inhibition by disrupting the
CD200:CD200R1 axis leads to an augmentation of pro-in-
flammatory signaling and increased recruitment of leukocytes
leading to the rapid clearance of virus.
Recently, the concept that inhibitory receptors can be
multifunctional and may be required for pro-inflammatory
signaling has emerged. For example, CD150 contains
a TxYxxV/I motif in its cytoplasmic tail that can bind SH2-
containing molecules, ranging from tyrosine and inositol phos-
phatases and Src family kinases to adaptor molecules. The
function of CD150 can vary depending on the molecule with
which it interacts [27]. CD200R1 has neither a conventional
ITIM nor an ITSM domain, and the range of its intracellular
functions is not known.
To understand how CD200R1 signaling impacts TLR2
function, we generated CD200R1
2/2 mice. In vitro, we compared
the ability of CD200R1
+/+ and CD200R1
2/2 macrophages to
generate cytokines/chemokines in response to the TLR2 agonist
Pam2CSK4 lipopeptide and to HSV-1. CD200R1
2/2 macro-
phages showed a marked decrease in the generation of both IL-6
and CCL5 (Rantes) in response to stimulation by both Pam2CSK4
and HSV-1, whereas no difference was observed in the generation
of any cytokine/chemokine in response to the TLR4 ligand
bacterial lipopolysaccharide (LPS). CD200R1
2/2 macrophages
also lacked the ability to up-regulate TLR2 expression in response
to HSV-1 infection. CD200R1
2/2 embryonic fibroblasts and
macrophages exhibited a defect in the replication of HSV-1.
In vivo, we found that CD200R1
2/2 mice showed both
markedly decreased morbidity and increased survival.
CD200R1
2/2 and CD200R1
+/+ mice did not show a statistically
significant difference in the brain inflammatory response. How-
ever, CD200R1
2/2 mice showed a marked decrease in in-
tracranial HSV-1 titers and expression of HSV-1 envelope
glycoproteins. CD200R1
2/2 showed a decrease in brain levels
of IFN-b consistent with the lower viral titers. These results are
distinct from those previously observed with TLR2
2/2 mice, and
support a defect in the responses to HSV-1 that include an
inability to support viral replication in the absence of CD200R1 in
addition to a defect in TLR2 responses.
Materials and Methods
Ethics Statement
This study was approved and performed in strict accordance
with the guidelines set forth by both the University of
Massachusetts Medical School Department of Animal Medicine
Institutional Animal Care and Use Committee (IACUC) (assur-
ance number A3306-01) and by the Massachusetts General
Hospital (MGH) Center for Comparative Medicine, Subcommit-
tee on Research Animal Care (SRAC), which serves as the
Institutional Animal Care and Use Committee (IACUC) at MGH
(assurance number A3596-01). Mice were bred and maintained
under specific-pathogen-free conditions at the animal facilities at
both the University of Massachusetts Medical School and the
Massachusetts General Hospital Charlestown Facility, and all
efforts were made to minimize suffering.
Antibodies
Anti-CD200R1 and anti-CD200 for cell surface staining were
purchased from AbD Serotec. Goat anti-CD200R1 intracellular
domain-specific antibody was from Santa Cruz. Anti-IL-1b was
goat polyclonal anti–mouse IL-1b (AF-401-NA; R&D Systems).
The primary antibody used in immunohistochemical studies was
rabbit polyclonal anti-HSV2 (B0116; Dako) and the secondary
antibody used was biotin-conjugated goat anti-rabbit (H+L) IgG
(656140; Invitrogen). The secondary anti-rabbit antibody used in
blotting studies was rabbit anti-goat (H+L) IgG HRP conjugate
(172–1034; Bio-Rad).
PCR Primers and Screening for CD200R1 Gene Targeting
Mice used were backcrossed to generation N9 or N10. To
identify the knockout allele in genomic DNA, tail vein DNA
was purified using the DNeasy kit (Qiagen). PCR was then
performed using the forward primer Neo1, located in the 59-
promoter region of the neo gene cassette (59-TGCGAGGC-
CAGGCCACTTGTGTAGC-39) combined with the reverse
primer CD200R1-rev, located outside the short arm of the
knockout construct (59-GGGATGCAGAACATAGGAGGCAG-
39) corresponding to a sequence within the first third of intron 1
of the CD200R1 gene. The PCR product yields a 1.5 kbp
product. To identify the wild-type allele primer WT1 (59-
CAGTAGTTTTGGAGAATGTGACAG-39) was combined
with WT-rev (59-GATAGCCCTTGCTCCTATGACTGAG-39)
to yield a 1.4 kbp product corresponding to a region of intron 1
that is present in WT DNA but is deleted by insertion of the
targeting construct. The PCR conditions for both sets of
primers were: (95uC, 15 min; 94uC, 30 sec; 62uC, 1 min; 72uC
2 min; 35 cycles using Thermo Start ReddyMix PCR master
mix (Thermo Scientific).
Exon-Specific screening. The following forward and re-
verse primers were combined to probe the expression of
CD200R1 exons in peritoneal macrophages: exon 1F (59-
ATGTTTTGCTTTTGGAGAACT-39) and exon 7R (59-CTA-
GATTCCAATGGCCGACAA-39) to amplify the full length
cDNA; exon 1F (above) and exon 5R (59-CACCTCTACT-
CAGTTCTATGG-39) to amplify exons 1–5; exon 5F (59-
TGAAGTAACCTACTTTCCAGA-39) and exon 7R (above) to
amplify exons 5–7. RNA was prepared using RNeasy (Qiagen)
and RT-PCR was performed using 1 unit Taq polymerase, and
Q solution (Qiagen). The PCR conditions for all pairs of
primers were: (94uC, 20 sec; 62uC, 20 sec; 72uC 2 min; 35
cycles).
Preparation and Stimulation of Peritoneal Macrophages
Mice were injected with 4% thioglycollate and peritoneal
exudate cells were routinely harvested 3–4 days later [6]. To
generate macrophages, peritoneal exudate cells were plated at 10
6
cells per well in 24-well plates in DMEM containing 10% FCS.
Lipopolysaccharide (LPS) was obtained from Sigma and phenol
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from EMC Microcollections (Tubingen, Germany).
Immmunohistochemistry and Viral Particle Detection
Tissues were recovered from mice at necropsy, fixed in
Bouin’s solution (Sigma-Aldrich), and embedded in paraffin. For
routine histology, 5 mm sections were stained with hematoxylin
and eosin. The sections were evaluated by a pathologist without
knowledge of the experimental design. For immunohistochem-
istry, fixed sections from CD200R1
+/+ and CD200R1
2/2 mice
were deparaffinized, antigen-unmasked using citric acid, probed
with antibody to HSV antigens [6], stained with biotin-
conjugated secondary antibody, and detected using avidin:bio-
tin-complexed HRP. The localization of HRP-labeled Ab was
detected using 3,39-Diaminobenzidine; hematoxylin was used as
a counterstain.
Histological Scoring of Brains
48 hours post-infection, mice were anesthetized with isoflurane
and euthanized by exsanguination. Brains were dissected and
stored in Bouin’s Fixative Formula (Fisher Scientific, Pittsburgh,
PA) for 24 h. Each brain was cut into 4 coronal sections, paraffin
embedded, sectioned, mounted and stained with hematoxylin and
eosin (H&E) by the histology core at University of Massachusetts
Medical School, Worcester, MA. To quantify the severity and the
extent of pathologic inflammation in the brains of HSV-1 infected
mice, a histologic inflammation scoring system was used. Each of
seven regions of the brain was assigned an inflammation score of
0 (no apparent inflammation), 1 (minimal inflammation), or 2
(above minimal inflammation). Inflammation was judged on the
presence and extent of cellular infiltrate and reactive gliosis. The
regions of the brain that were scored were: frontal cerebral cortex,
posterior cerebral cortex, hippocampus, diencephalon/mesen-
cephalon (which includes the thalamus, hypothalamus and
brainstem), cerebellum, the caudal paraventricular structures
(defined as those areas adjacent to the lateral ventricles), and the
rostral paraventricular structures (defined as those areas adjacent
to the 3
rd ventricle, the cerebral aqueduct, and the 4
th ventricle).
Each brain was scored blindly by two observers. The scores for
each of the seven regions were summed to arrive at a total brain
inflammation score for each mouse with a maximum possible
score of 14.
Generation and Analysis of HSV-1-specific CD8+ T Cells
To analyze the generation of viral-specific CD8+ T cell
generation, mice were infected intraperitoneally with 10
4 PFU of
HSV-1. On days 5–9, 50 ml of peripheral blood was withdrawn
from tail veins and cells were stained for CD8 antigen using an
anti-CD8 APC-conjugated monoclonal antibody, and probed for
binding of the SSIEFARL-H2-K
d-PE gB peptide-(aa 498–505)
(gB498–505) MHC pentamer [29] to identify HSV-1 specific CD8+
positive T cells [30]. The percentage of CD8 positive cells that
were also positive for gB pentamer binding was determined by
flow cytometric analysis. (All antibodies were from eBioscience and
BD Biosciences, San Diego, CA, while HSV-1 gB
+
498–505
pentamer was from ProImmune Inc., Bradenton, FL). Cells were
incubated with CD3/CD11b/CD8/gB
+
498–505 pentamer and
monoclonal antibodies following the manufacturer’s protocol.
Stained cells were washed twice with FACS buffer and fixed with
BD Cytofix/Cytoperm solution for 20 min at 4uC. Following
fixation, the cells were washed twice in BD Perm/Wash buffer,
resuspended in 4% paraformaldehyde, and analyzed using
a multicolor five-laser LSR II instrument (BD Biosciences, San
Diego, CA).
Preparation of Viruses
HSV-1 strains including viruses expressing ICP8-GFP [31] were
generated in the laboratory of Dr. David Knipe. Viruses were
added to MEFs and peritoneal macrophages at an M.O.I. of 10:1.
Statistical Analysis
An unpaired, two-tailed Student’s t-test or a Kruskal Wallis test
was used to determine statistical significance where indicated.
Statistics were performed using GraphPad (Prism v5.0d) software.
Values of P,0.05 were considered significant.
Results
Gene Targeting of Mouse CD200R1
We developed a gene targeting strategy to delete the expression
of the entire CD200R1 protein including the cytoplasmic tail and
transmembrane region (Figure S1) to prevent the formation of
a truncation mutant that could function as a dominant negative,
potentially disrupting the interaction of other signaling molecules.
This strategy was therefore distinct from that of a previously
generated CD200R1
2/2 mouse in which only exons 2–4 (the
extracellular domain) were targeted [32]. The targeting vector
(Figure S1A) was constructed by using a 1.3 kbp DNA fragment as
the short arm. The long arm was a 10 kbp genomic fragment,
which starts from EcoRV to SpeI. In this strategy, 1.2 kbp
upstream of the ATG start codon, exon 1, and 2.9 kbp of intron 1
were replaced by the Neo gene cassette, resulting in a frame shift
mutation and the generation of stop codons in each of the 3
reading frames. To confirm successful gene targeting, DNA was
prepared from tail veins and analyzed by both PCR and Southern
blot. For Southern blotting, tail vein genomic DNA was digested
with Nsi1, resolved by 0.7% agarose gels, transferred to
nitrocellulose membranes, and then probed with a 550 bp
genomic fragment localized within intron 1 to distinguish targeted
and CD200R1
+/+ DNA. As shown in Figure S1B, DNA from
CD200R1
+/+ mice gave a predicted single band of 7.8 kbp.
CD200R1
2/2 DNA showed a single band of the predicted size of
2.7 kbp. Both bands were detected in DNA from heterozygote
mice. When analyzed by PCR, tail vein DNA of CD200R1
2/2
mice showed a characteristic 1.5 kbp band that was absent in
CD200R1
+/+ DNA (Figure S1C), whereas CD200R1
+/+ tail vein
DNA showed only a 1.4 kbp band. DNA from heterozygous mice
showed both bands. Finally, when analyzed by flow cytometry,
CD200R1
+/+, but not CD200R1
2/2 elicited peritoneal macro-
phages expressed CD200R1 (Figure S1D).
CD200R1 Licenses Pro-inflammatory Signaling by TLR2 in
Macrophages
HSV-1 initiates cytokine and chemokine synthesis in the brain
via stimulation of TLR2 expressed on macrophages, which are
derived from peripheral blood monocytes [6,7,8,9], as well as on
glial and microglial cells. We therefore examined the interaction of
HSV-1 with CD200R1
+/+ and CD200R1
2/2 macrophages.
Elicited macrophages from both CD200R1
+/+ and CD200R1
2/
2 mice were infected with HSV-1 (multiplicity of infection;
MOI=10), or challenged with Pam2CSK4 (100 ng/ml), or LPS
(100 ng/ml), and levels of IL-6, CCL5 (Rantes), or CCL2 (MCP-1)
were measured at 24, 48, and 72 h. HSV-1 infected CD200R1
+/+
macrophages produced 35,000 pg/ml IL-6 24 h after stimulation,
which rose to 60,000 pg/ml by 48 h and 72 h (Figure 1A). In
contrast, CD200R1
2/2 macrophages only generated between
20,000 to 30,000 pg/ml IL-6 in response to HSV-1 stimulation.
Pam2CSK4 stimulated IL-6 levels averaged 70,000 to 80,000 pg/
ml over the 3 day experiment in CD200R1
+/+ cells, whereas
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2/2 macrophages generated only 10,000 to 20,000 pg/
ml. Similar to the IL-6 response, the generation of CCL5 (Rantes)
by CD200R1
2/2 macrophages stimulated with HSV-1 was
blunted when compared to CD200R1
+/+ macrophages. To
address whether the decrease in CCL5 (Rantes) was a property
of signaling by TLR2, or secondary to low levels of IFN, we
determined whether CD200R1
2/2 peritoneal macrophages
exhibit a blunted CCL5 (Rantes) response to stimulation with
the TLR4 ligand LPS. In contrast to the attenuated response to
TLR2 stimulation, there was only a modest decrease in the levels
of IL-6 at 24 h and 48 h and no difference in the levels of CCL5
(Rantes) generated in response to TLR4 stimulation via LPS in
CD200R1
+/+ or CD200R1
2/2 cells at any time point (Figure 1A).
In the case of CCL2 (MCP-1) generation, no difference was found
between CD200R1
2/2 and CD200R1
+/+ with any stimulant;
though LPS induced a marked increase in CCL2 (MCP-1)
expression in CD200R1
2/2 cells.
The formation of mature IL-1b requires two distinct steps
[33,34]. The first signal induces the generation of pro-IL-1b.
Expression of pro-IL-1b is regulated at the transcriptional level by
NF-kB, which, for HSV-1, is activated downstream of TLR2
signaling. The second signal activates assembly of the inflamma-
some complex and cleavage of pro-IL-1b into its mature secreted
form, IL-1b. This can be triggered by a variety of mechanisms,
including extracellular ATP acting on the P2X receptor, reactive
oxygen species, or potassium efflux triggered by the antibiotic
Nigericin [35]. The interaction of double stranded DNA and viral
replication intermediates with intracellular DNA sensors can also
induce inflammasome assembly [3,36,37,38,39,40]. The assembly
and function of the inflammasome is therefore dependent on the
quantity of viral replication intermediates within cells. We
therefore hypothesized that if CD200R1 was required for efficient
viral replication, then CD200R1
2/2 macrophages should show
lower levels of inflammasome formation and impaired conversion
of pro-IL-1b to IL-1b.
Stimulation of CD200R1
2/2 peritoneal or bone marrow-
derived macrophages with HSV-1 led to the production of
approximately 20% of the mature IL-1b levels seen in
CD200R1
+/+ cells (Figure 1B). In contrast, no difference was
found in mature IL-1b levels between CD200R1
+/+ or
CD200R1
2/2 macrophages stimulated with LPS (100 ng/ml)
for 3 h followed by the addition of ATP (1 mM) for 1 h. These
results suggested that that there was no intrinsic defect in
inflammasome formation or in the capacity of CD200R1
2/2
macrophages to generate pro-IL-1b mRNA while virus-induced
inflammasome formation was significantly attenuated in
CD200R1
2/2 macrophages. The difference in the production of
mature IL-1b between CD200R1
+/+ and CD200R1
2/2 macro-
phages following HSV-1 infection were confirmed by Western blot
(Figure 1C).
CD200R1 Expression Regulates TLR2 Expression in
Macrophages
Because of the key role of TLR2 in mediating the response of
macrophages to HSV-1 [6,9], we examined the relationship
between TLR2 expression on the surface of peritoneal macro-
phages, CD200R1 expression, and HSV-1 infection. The expres-
sion of CD200R1 on the surface of WT and TLR2
2/2 elicited
macrophages was determined by flow cytometry 24 h after
infection with HSV-1 (Figure 2A). As an internal control,
CD200R1
2/2 cells were also included. There was no difference
in CD200R1 expression levels between TLR2
+/+ and TLR2
2/2
macrophages. Interestingly, the surface expression of CD200R1
decreased 24 h after HSV-1 infection in both WT and TLR2
2/2
macrophages (Figure 2A). This was contrasted with the effect of
CD200R1 on TLR2 expression. Following HSV-1 infection,
TLR2 expression levels increased 12-fold in WT cells, but TLR2
expression was not increased in CD200R1
2/2 macrophages
(Figure 2B). These results indicated that CD200R1 directly
controls the inducible surface expression of TLR2 either directly
or secondary to decreased viral replication and that it may play
a role in the amplification of HSV-1 infection.
CD200R1
2/2 Mice are Protected from Intracranial HSV-1
Infection
The CD200R1:CD200 axis is known to down-regulate in-
tracranial inflammation, typified by studies of the EAE model
[17,18]. Because morbidity and mortality to HSV-1 infection is
secondary to increased brain inflammation (as well as lytic virus
replication), we predicted that CD200R1
2/2 mice would have
a marked increase in both brain inflammation and mortality when
compared to CD200R1
+/+ mice. To examine the effect of the
CD200R1:CD200 axis in the intracranial inflammation associated
with HSV-1 infection, CD200R1
+/+ and CD200R1
2/2 mice were
infected with 10
5 PFU of HSV-1 by intracranial injection, and the
survival in each group was followed daily for 15 days. CD200R1
+/
+ mice showed a characteristic survival curve (Figure 3), with 40%
of the mice surviving by day 6 and 26% by day 9. No further
mortality after day 9 was observed. In contrast, CD200R1
2/2
mice exhibited significantly higher survival rates, with 75% of the
mice surviving on day 6, and no further deaths within the course of
the experiment.
Cytokine/chemokine Levels in the Brains of CD200R1
+/+
and CD200R1
2/2 Mice is Indistinguishable after
Intracranial HSV-1 Infection
To explain these apparently paradoxical results, we examined
a series of parameters that define intracranial inflammation
associated with HSV-1 infection. CD200R1
+/+ and CD200R1
2/
2 mice were infected with HSV-1 and their brains were harvested
and analyzed to assess inflammation 1 and 4 days post-infection.
Brains were homogenized and intracranial levels of three cytokines
known to be associated with and/or causative for HSV-1 mediated
brain inflammation and that are also linked with the outcome of
HSV-1 encephalitis, IL-6, CCL5 (Rantes) and CCL2 (MCP-1)
[6,9,12,13,14,15] were measured. Levels of IL-6 are known to
correlate with the level of viral infection [12,15], and IL-6
2/2
mice have more severe HSV-1 encephalitis, with increased
morbidity and death than IL-6
+/+ mice [12]. Levels of IL-6 were
statistically indistinguishable between CD200R1
+/+ and
CD200R1
2/2 brains on day 1, and were essentially at baseline
levels by day 4 (Figure 4A). Similarly, CCL5 (Rantes) and CCL2
(MCP-1) levels were not statistically different between CD200R1
+/
+ and CD200R1
2/2 brains on day 1 or day 4 (Figures 4B and 4C),
though the differences in Rantes (CCL5) and MCP-1 (CCL2) on
day 4 were trending towards significance with p-values of p=0.09
and p=0.07, respectively.
HSV-1 Induced Type I IFN Production is Significantly
Lower in CD200R1
2/2 Mice
During the initial phase of HSV-1 disease, viral replication is
controlled to a large extent by the production of type I IFN and
the expression of IFN-response genes [9,41,42,43,44,45,46].
Therefore, we determined levels of IFN-b in the brains of
CD200R1
2/2 and CD200R1
+/+ mice following intracranial
HSV-1 infection. On day 1, CD200R1
2/2 brains had significantly
lower levels of IFN-b than CD200R1
+/+ mice (Figure 4D). On day
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2/2 remained statistically lower
than CD200R1
+/+ mice, though both exhibited a decrease from
day 1 levels. In addition, serum IFN-b levels in CD200R
2/2 mice
were 76% lower compared to the levels found in CD200R1
+/+
mice.
CD200R1
2/2 Mice Have Lower Brain Viral Titers than
CD200R1
+/+ Mice
No difference in gross pathology between CD200R1
+/+ and
CD200R1
2/2 brains was observed on day 3 post HSV-1 infection
(Figure 5A). Leukocyte infiltration was assessed in 7 regions of the
brain and each region received a score of 0 (no leukocytes), 1 (rare
or occasional leukocyte infiltration) or 2 (marked leukocyte
infiltration). Total scores were determined in a blinded manner
by 2 observers. Both CD200R1
+/+ and CD200R1
2/2 brains
showed indistinguishable degrees of leukocyte infiltration in both
regional and compiled pathologic scores (Figure 5B).
The lack of difference in brain leukocyte scores, and in CCL2
(MCP-1), CCL5 (Rantes), and IL-6 levels indicated that
CD200R1
2/2 mice had equivalent or modestly reduced brain
inflammation, rather than an enhanced, inflammatory response to
HSV-1 infection compared to CD200R1
+/+ mice (see above).
When combined with the observation that CD200R1
2/2 mice
had lower levels of IFN-b in brain and serum, the results suggest
that there is decreased replication of HSV-1 in CD200R1
2/2
brains. To test this conclusion, CD200R1
+/+ and CD200R1
2/2
mice were infected intracranially with 10
5 PFU HSV-1, and virus
titers in whole brain homogenates were determined by plaque
assay using Vero cells on days 1, 3, and 4 post-infection
(Figure 5C). On day 1, brain titers were comparable between
CD200R1
+/+ and CD200R1
2/2 mice. Though viral titers
Figure 1. CD200R1 licenses pro-inflammatory signaling in peritoneal macrophages. (A) CD200R1
+/+ (WT) or CD200R1
2/2 (KO) elicited
peritoneal macrophages were stimulated with either HSV-1 (MOI 10:1, left column), Pam2CSK4 (100 ng/ml, center column), LPS (100 ng/ml, right
column), or medium for 24, 48, or 72 h. IL-6 (upper row, pg/ml), CCL5/Rantes (middle row, pg/ml), and CCL2/MCP1 (lower row, pg/ml) levels were
measured by ELISA. Data shown are mean and SD of representative experiment (total of 3 experiments, n=4, WT and KO). An unpaired, two tailed
Student’s t-test was used to determine statistical significance of independent experiments, p values; * p,0.05, { p,0.01. (B) Supernatant IL-1b levels
from WT and KO elicited peritoneal macrophages (left panels) or bone marrow macrophages (right panels) 16 h after addition of HSV-1 (MOI 10:1) or
after a 3 h stimulation with LPS (100 ng/ml) followed by ATP (1 mM) for 1 h. ELISA results are representative of 3 experiments. (C) WT and KO elicited
peritoneal macrophages were cultured for 20 h with HSV-1 (MOI 10:1). Media (left lanes) and cells (right lanes) were analyzed by SDS-PAGE followed
by Western blot for cleavage of pro-IL-1b to IL-1b. Data representative of 3 experiments (n=4, WT; n=5, KO).
doi:10.1371/journal.pone.0047740.g001
Figure 2. CD200R1 controls expression of TLR2 in macro-
phages. (A, B) The expression of CD200R1 (A) or TLR2 (B) on the
surface of WT (circles), TLR2KO (squares), or CD200R1KO (triangles)
elicited peritoneal macrophages (MW) before (–, closed symbols) or
after HSV-1 infection (+, open symbols) was determined by flow
cytometry. The lack of expression of CD200R1 or TLR2 on the surface of
CD200R1KO or TLR2KO macrophages, respectively, served as internal
controls. Data representative of 3 experiments (preparations from
individual mice n=3 WT and KO are shown). An unpaired, two tailed
Student’s t-test was used to determine statistical significance of
independent experiments.
doi:10.1371/journal.pone.0047740.g002
Figure 3. CD200R1
2/2 mice are protected from HSV-1 enceph-
alitis. CD200R1
+/+ (WT) and CD200R1
2/2 (KO) mice were administered
10
5 PFU HSV-1 by intracranial injection. Survival was monitored for 15
days. Data includes a total of 3 separate experiments (n=20, WT; n=16,
KO). An unpaired, two tailed Student’s t-test was used to determine
statistical significance.
doi:10.1371/journal.pone.0047740.g003
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2/2 mice exhibited
significantly lower titers than CD200R1
+/+ mice (not shown).
HSV-1 titers were negligible in CD200R1
2/2 brains by day 3,
with 60% of CD200R1
2/2 mice having brain titers that were
below the limit of detection. In contrast, HSV-1 titers from
CD200R1
+/+ brains were unchanged from day 1 to day 3. On day
4, viral titers from CD200R1
+/+ brains had dropped slightly
compared to their titers on day 3 but this was not statistically
different. CD200R1
2/2 mice, however, continued to have a high
percentage of animals (42%) that had completely cleared the
infection. Overall, the HSV-1 titers in CD200R1
2/2 mice were
lower compared to CD200R1
+/+ mice on day 4 but the difference
in titers did not reach statistical significance. Importantly,
approximately 50% of the CD200R1
2/2 mice had cleared the
infection by days 3 and 4, while HSV-1 continued to replicate at
high levels in 100% of CD200R1
+/+ mice.
To assess the extent and distribution of HSV-1 infection in
CD200R1
2/2 and CD200R1
+/+ brains, we determined the
expression of HSV-1 viral antigens by immunohistochemical
staining 3 days post-intracranial infection. HSV-1 antigens were
detected in a large percentage of neurons in and around the
hippocampus of CD200R1
+/+ mice (Figure 5D). In contrast,
CD200R1
2/2 mice had much less extensive neuron involvement
with fewer HSV-1 positive neurons in the hippocampal region.
In response to HSV-1 infection, the host generates CD8
+ cells
that recognize the HSV-gB protein. The HSV-1-specific CD8+
response is dependent on the viral load [29,30]. A majority of the
CD8+ cells are directed to a single dominant gB498–505 peptide
and will specifically bind a MHC-gB-peptide-pentamer that can
be monitored by flow cytometry [29,30,47,48,49]. CD200R1
+/+
and CD200R1
2/2 mice were infected with 10
4 PFU HSV-1 by
intraperitoneal injection. The development of HSV-gB pentamer-
specific CD8
+ peripheral blood T cells was monitored up to 9 days
post-infection (Figure 5E). In CD200R1
+/+ mice, the percentage of
gB-pentamer positive cells peaked 7 days after infection at
approximately 14.4%, which decreased by half by day 9
(Figure 5E). In contrast, CD200R1
2/2 mice showed a blunted
and delayed response that gradually rose to approximately 6.5%
by day 9. This blunted CD8+ response is consistent with reduced
HSV-1 replication in CD200R1
2/2 mice and provide additional
evidence that CD200R1
2/2 mice either more efficiently eliminate
HSV-1 or lack the ability to support its sustained replication.
CD200R1 Expression Increases HSV-1 Infection ex vivo in
Mouse Embryonic Fibroblasts and Peritoneal
Macrophages
To explore the role of CD200R1 in supporting viral replication,
we generated mouse embryonic fibroblasts (MEFs) from
CD200R1
+/+ and CD200R1
2/2 mice and infected them with
an HSV-1 strain that expressed a green fluorescent protein (GFP)
fusion protein of the delayed early gene ICP8 (ICP8-GFP). We
monitored the expression of GFP by flow cytometry for up to 20 h
after infection. The expression of ICP8-GFP peaked in
CD200R1
+/+ cells at 12 h after infection, with over 40% of the
cells expressing GFP (Figure 6A). In contrast, CD200R1
2/2
MEFs expressed less than half this amount.
We then tested the ability of CD200R1
2/2 and CD200R1
+/+
peritoneal macrophages to be infected with HSV. Macrophages
were infected with ICP8-GFP expressing HSV-1 and GFP
expression was monitored for up to 144 h. ICP8-GFP expression
peaked at 24 h, at which time 10.8% of CD200R1
+/+ macro-
Figure 4. CD200R1
2/2 and CD200R1
+/+ brains have distinct cytokine response profiles. (A-D) Cytokine levels were measured in CD200R1
+/
+ (WT, open triangles) and CD200R1
2/2 (KO, closed circles) brains on days 1 and 4 (D1 and D4) post-cranial injection of 10
5 PFU HSV-1. (A) IL-6; (B)
CCL2/MCP-1; (C) CCL5/Rantes; (D) IFN-b. The mean of each group is indicated by a horizontal bar. The statistically significant groups, as determined
by Kruksal Wallis test, are linked by bars and have p-values listed. (E) IFN-b levels were measured in the serum of CD200R1
+/+ (WT, open triangles) and
CD200R1
2/2 (KO, closed circles). Statistical analysis was performed as above. Data includes a total of 5 experiments each with 3–7 mice per genotype
(n=20 WT and n=13 KO day 1; n=7, WT and KO day 4).
doi:10.1371/journal.pone.0047740.g004
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CD200R1
2/2 macrophages expressed ICP8-GFP (Figure 6B).
This was consistent with the results seen in MEFs. Thus HSV-1
infection was attenuated both in CD200R1
2/2 macrophages and
fibroblasts. We confirmed that both elicited peritoneal macro-
phages and MEFs expressed CD200R1 by immunofluorescence
(Figure 6C). Furthermore, neither macrophages nor MEFs express
CD200 message or protein (not shown); therefore the impact of
Figure 5. CD200R1
2/2 mice clear HSV-1 virus more efficiently than CD200R1
+/+ mice. (A) H&E staining of CD200R1
+/+ (WT) and CD200R1
2/
2 (KO)
- brain sections prepared on day 3 post-intracranial infection (106). Data is representative of 2 separate experiments each with 3–5 mice per
genotype (n=7 WT and n=8 KO). (B) Total leukocyte infiltration scores from 7 regions of the brain on day 3 post-intracranial infection. (C) HSV-1 titers
in WT (open triangles) and KO (closed circles) brain homogenates on days 1, 3, and 4 post-intracranial infection by plaque assay. Limit of detection
(LLD) indicated by dashed line. Data includes a total of 4 experiments (n=14, WT day 1; n=13, KO day 1; n=5, WT and KO day 3; n=7, WT and KO
day 4). (D) HSV-1 antigen expression in WT and KO infected brains (106). Inset images are 40X zoom of boxed areas. Data includes 2 experiments
(n=6 WT and KO). (E) WT (open triangles) and KO (closed circles) CD8+ T cells were probed for binding of the SSIEFARL-H2-K
d-PE gB peptide-(aa 498–
505) MHC pentamer to identify HSV-1 specific CD8+ T cells on days 5–9 post-intraperitoneal infection. The mean of each group is indicated by
a horizontal bar. Statistically significant groups (as determined by an unpaired, two-tailed Student’s t-test analysis) are linked by bars, or indicated by
asterisks and have p-values listed. Data are from n=3, WT and KO.
doi:10.1371/journal.pone.0047740.g005
CD200R1 Supports HSV Replication and TLR2 Signals
PLOS ONE | www.plosone.org 8 October 2012 | Volume 7 | Issue 10 | e47740CD200R1 on HSV-1 infection was independent of
CD200R1:CD200 interaction but was dependent on CD200R1
expression itself. Overall, our findings indicate that CD200R1
plays an important intrinsic role in regulating TLR2 expression
and signaling. In a TLR2-dependent viral model like such as
HSV-1 infection, lack of CD200R1 expression leads to decreased
inflammatory cytokine/chemokine production as well as a failure
to upregulate TLR2, thus suggesting a link between TLR2
signaling and decreased viral titers.
Discussion
The CD200R1:CD200 axis has traditionally been considered to
be down-regulatory in inflammatory settings. In models of EAE,
Toxoplasma encephalitis, experimental autoimmune retinitis, colla-
gen-induced arthritis and influenza-induced pneumonitis,
CD200
2/2 mice show enhanced inflammatory responses
[17,18,24]. In the case of mouse hepatitis corona virus, the
increased survival was attributed to release of inhibition, increased
inflammation, and increased viral clearance. Therefore, the
dramatic increase in survival of CD200R1
2/2 mice compared
to CD200R1
+/+ mice in response to intracranial HSV-1 appears
to be paradoxical, or potentially explained by the same process.
Though a large component of the mortality seen in HSV-1
encephalitis in C57BL/6 WT mice (with an intact type I IFN
response) is secondary to the inflammatory response [6,8,9], our
results emphasize that viral replication, as opposed to inflamma-
tion, can also be a key component of the lethal effects of HSV-1
encephalitis in mice. This was supported by the observation that
no difference was found between brain chemokine/cytokines levels
(with the exception of interferon-b, a marker for viral load) or in
leukocyte recruitment into the brains of CD200R1
+/+ and
CD200R1
2/2 mice. In contrast, our data strongly support
a requisite role for CD200R1 in supporting the replication of
HSV-1, and implicate decreased viral replication as the reason for
increased viability of CD200R1
2/2 mice. Thus, although brain
titers of HSV-1 in CD200R1
+/+ and CD200R1
2/2 mice were
similar on day 1 post-infection, sustained virus infection was found
only in wild type and not in knockout mice. A large proportion of
CD200R1
2/2 mice were essentially free of replicating virus by
day 3–4 post-infection in contrast to CD200R1
+/+ mice which
continued to produce infectious HSV-1 virions in their brains over
the entire 4 day course of the study.
Our results demonstrate decreased HSV-1 viral titers (in many
cases below the limit of detection) and reduced immunohisto-
chemical detection of HSV-1 in the brains of CD200R1
2/2 mice.
Consistent with the reduced levels of brain infection in
CD200R1
2/2 mice we found decreased interferon levels in the
brains of CD200R1
2/2 compared to CD200R1
+/+ mice. The
decreased ability of HSV-1 to infect and/or replicate in tissues
outside the brain in CD200R1
2/2 mice was supported by the
blunted HSV-1-specific CD8+ T cell response to intraperitoneal
HSV-1 infection. Finally, a role for CD200R1 in supporting viral
replication was found by comparing elicited peritoneal macro-
phages and MEFs from CD200R1
+/+ and CD200R1
2/2 mice, in
which viral infection was decreased in CD200R1
2/2 cells.
A unique role for CD200R1 in supporting (licensing) pro-
inflammatory signaling by TLR2 was also found. This role was
revealed by studies with elicited peritoneal macrophages in which
the generation of IL-6 and CCL5 (Rantes) in CD200R1
2/2
macrophages was blunted by ,80% in response to TLR2 ligands
and HSV-1; this was not observed in response to LPS suggesting
a specific defect in TLR2-driven responses. Furthermore,
CD200R1
2/2 macrophages lacked the ability to assemble
a functional inflammasome. It is unclear why IL-6 and CCL5
(Rantes) but not MCP-1 levels were reduced in CD200R1
2/2
Figure 6. CD200R1 regulates replication of HSV-1 in cells. (A, B)
Flow cytometric analysis of GFP expression in CD200R1
+/+ (WT) and
CD200R1
2/2 (KO) mouse embryonic fibroblasts (MEFs; A) and elicited
peritoneal macrophages (B) at various time points following infection
with ICP8-GFP virus (MOI 10:1). Histograms of each sample were
generated. A gate was set on the uninfected control for each condition,
which excluded 99% of the uninfected cells. This gate was applied to
the paired infected samples to calculate the % GFP+ cells. Data
representative of 3 experiments. (C) CD200R1 expression on MEFs (left
panel) or elicited peritoneal macrophages (MW, right panel) was
determined using immunofluorescence staining. Scale bar=10 mm.
Data representative of 3–4 experiments (MW from n=6, WT and KO).
doi:10.1371/journal.pone.0047740.g006
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and CCL2 (MCP-1) generation via TLR2 signaling. Although
these cytokines are both NF-bB driven, there are distinct
transcription factors that drive expression of IL-6 or MCP-1. In
previous studies we have noted that HSV-induced IL-6 is strictly
dependent on TLR2 expression while some MCP-1 secretion still
occurs in TLR2
2/2 cells, albeit at reduced levels compared to
TLR2
+/+ macrophages [9]. Currently, the mechanism(s) are not
known. It is also possible that CD200R1 regulates IL-6 and CCL2
(MCP-1) differently. It is also unclear why the expression of CCL5
(Rantes) but not CCL2 (MCP-1) is decreased in CD200R1
2/2
mice. It is possible that CCL5 (Rantes) secretion is secondary to
decreased IFN, though ultimately this also is a consequence of the
control of TLR2 signaling by CD200R1. An additional defect in
TLR2 function, the inability to up-regulate the expression of
TLR2 in response to HSV-1 infection, may contribute to the
inability to perpetuate and amplify HSV-1 infection, though this
may be secondary to the role of CD200R1 in regulating viral
replication.
The role of CD200R1:CD200 interaction in determining the
host response to pathogens is complex, and, when considered in
the context of our current studies, is likely to be dependent on the
mechanisms that the host uses to kill the specific pathogen. In the
case of influenza and meningococcus, CD200
2/2 mice are prone
to the effects of inflammation/sepsis [18,23], indicating that
CD200R1:CD200 interaction is not likely to be involved in the
regulation of cellular anti-viral mechanisms. As described above,
this is also the case for Toxoplasma encephalitis [24]. In regards to
Leishmania, redox defense mechanisms used by the host are
suppressed by the CD200R1:CD200 axis in L. amazonensis, which
induces CD200 expression in host cells, so that CD200
2/2 mice
are protected from the pathogen. However L. major grows more
slowly in macrophages and does not induce CD200 expression in
host tissue [25]. In the case of HSV-1 and other members of the
Herpesviridae family, the situation is somewhat analogous, but is
more complex and involves a clearly distinct mechanism. In HSV-
1, CD200R1 supports infection at or before the stage of early gene
expression, which in turn regulates the surface expression of
TLR2. Whether additional CD200R1-independent or CD200R1-
dependent (intrinsic) intracellular mechanisms controlling viral
replication are involved are not yet known, but would not be
surprising. The decreased infection of HSV-1 at all time points in
CD200R1
2/2 MEFs as well as macrophages indicates that the
situation is more complex than simply the suppression of a virus-
toxic metabolite such as NO, which can be driven or amplified by
TLR2. The effect of CD200R1 on HSV-1 infection in MEFs and
macrophages occurred in the absence CD200 expression suggest-
ing that CD200R1 intrinsically regulates virus replication. Because
HSV-1 is a neurotropic virus and neurons express CD200 but not
CD200R1 on their surface [50,51], how the macrophage-specific
mechanisms elucidated by our work function to exert their
profound impact on HSV-1 replication and host survival in vivo are
not straightforward. Even though macrophages and dendritic cells
are relatively resistant to HSV-1 infection [52], our data indicate
that they have the potential to be infected, and therefore could be
important in mediating intraneuronal transmission or to serve as
a reservoir of virus. As CD200R1
2/2 macrophages would be
deficient in these processes, the lack of CD200R1 could potentially
slow the spread of virus within the brain. Alternatively or
concomitantly, CD200R1
+/+ macrophages may generate a factor
that is required to sustain viral replication in neurons, or
CD200R1
2/2 macrophages may contribute to increased viral
killing. Furthermore, how the impact of CD200R1 on TLR2
signaling affects viral replication in vivo is not fully elucidated.
HSV-1 is known to target components of the TLR2 signaling
pathway via expression of the viral protein ICP0, suggesting that
TLR2 biology and HSV-1 biology are linked [53].
The selective requirement for the induction of IL-6 and CCL5
(Rantes) expression by TLR2 ligands and HSV-1 is consistent with
the emerging concept that inhibitory receptors can be multifunc-
tional and be required for pro-inflammatory signaling. CD150
contains a TxYxxV/I motif in its cytoplasmic tail that can bind
SH2-containing molecules, ranging from tyrosine and inositol
phosphatases and Src family kinases to adaptor molecules. The
function of CD150 can vary depending on the molecule with
which it interacts [27]. CD200R1 has neither a conventional
ITIM nor an ITSM domain, and the range of potential
interactions with its cytoplasmic tail is not known. Another
example of a dual role for inhibitory receptors is the fact that for
their activation receptors to become activated, NK cell inhibitory
receptors must first interact with their cognate self-MHC ligands
[54]. In fact, the role of CD200R1 in supporting the synthesis of
IL-6 and CCL5 (Rantes) may not be direct. The blunted
generation of IL-6 and CCL5 (Rantes) was determined after
24 h, so signaling by CD200R1 could impact the synthesis of other
cytokines, which in turn regulate the generation of IL-6 and CCL5
(Rantes). However, the role of CD200R1 in regulating the surface
expression of TLR2 expression suggests a direct link between these
pathways.
Supporting Information
Figure S1 Gene Targeting of CD200R1. (A) Development of
the targeting construct. (B) Southern blot of tail vein DNA from
CD200R1
2/2 (2/2), CD200R1
+/+ (+/+), and CD200R1
+/2 (+/
2) mice. The 7.8 kbp band indicates the WT allele, whereas the
2.8 kbp band is diagnostic of a gene-targeted allele. (C) PCR
analysis of tail vein DNA from CD200R1
2/2 (2/2), CD200R1
+/
+ (+/+), and CD200R1
+/2(+/2) mice. The gene-targeted allele is
represented by a 1.5 kbp band and the WT allele is represented by
a 1.4 kbp band. (D) Flow cytometric analysis of elicited peritoneal
macrophages from CD200R1
+/+ (WT) and CD200R1
2/2 (KO)
macrophages probed for the expression of CD200R1.
(PDF)
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